Trial Profile
Clinical Trials Insight: 700009424
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2005
Price :
$35
*
At a glance
- Drugs EMZ 701 (Primary) ; Interferon beta (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Transition Therapeutics
- 29 Nov 2005 New trial record.